About Melinda Lerwill, MD
Dr. Melinda Lerwill received her B.A. from Johns Hopkins University and her M.D. summa cum laude from Harvard Medical School. She completed her residency training in Anatomic Pathology and her fellowship training in Breast and Gynecological Pathology at Massachusetts General Hospital. Dr. Lerwill is an Associate Pathologist at Massachusetts General Hospital, where she is director of the breast pathology service and breast pathology fellowship. She is an Assistant Professor of Pathology at Harvard Medical School. Dr. Lerwill is a frequent lecturer at national and international post-graduate courses. She has authored chapters on breast and gynecologic pathology in several major textbooks, including Rosen's Breast Pathology, Blaustein's Pathology of the Female Genital Tract, and Sternberg's Diagnostic Surgical Pathology. Her academic interests focus on early neoplasia of the breast, biphasic tumors of the breast, metastatic lesions to the gynecological tract, and graduate medical education.
Clinical Interests:
- Breast pathology
- Gynecologic pathology
Treats:
- Adult
Locations
Mass General Pathology
55 Fruit St.
Boston, MA 02114
Phone: 617-643-0800
Medical Education
- MD, Harvard Medical School*
- Residency, Massachusetts General Hospital
American Board Certifications
- Anatomic Pathology, American Board of Pathology
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Maine Community Health Options
- Mass General Brigham Health Plan
- MassHealth
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Railroad Medicare
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Current areas of clinicopathologic investigation include:
-
Early epithelial neoplasia of the breast
-
Phyllodes tumors and other biphasic lesions of the breast
-
Use of immunohistochemistry as a diagnostic aid in breast pathology
-
Metastatic tumors to the ovary
Publications
-
- Case records of the Massachusetts General Hospital. Case 1-2015. A 66-year-old woman with metastatic breast cancer after endocrine therapy. Moy B, Specht MC, Lanuti M, Rafferty EA, Lerwill MF. N Engl J Med. 2015 Jan 8;372(2):162-70. doi: 10.1056/NEJMcpc1408601. No abstract available.
- Computational pathology to discriminate benign from malignant intraductal proliferations of the breast. Dong F, Irshad H, Oh EY, Lerwill MF, Brachtel EF, Jones NC, Knoblauch NW, Montaser-Kouhsari L, Johnson NB, Rao LK, Faulkner-Jones B, Wilbur DC, Schnitt SJ, Beck AH. PLoS One. 2014 Dec 9;9(12):e114885. doi: 10.1371/journal.pone.0114885. eCollection 2014.
- Case records of the Massachusetts General Hospital. Case 17-2011. A 49-year-old woman with a mass in the breast and overlying skin changes. Overmoyer BA, Lee JM, Lerwill MF. N Engl J Med. 2011 Jun 9;364(23):2246-54. doi: 10.1056/NEJMcpc1100922. No abstract available.
Reviews: Comments and Ratings
Patient Gateway
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
A Top Hospital in America
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.